Dr. John C. McCann
Claim this profileBaystate Medical Center
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
16 reported clinical trials
40 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage III
Stage I
2Non-Small Cell Lung Cancer
Stage IV
Stage III
Stage I
Affiliated Hospitals
Clinical Trials John C. McCann is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about John C. McCann
Clinical Trial Related2 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments John C. McCann has experience with
- Nivolumab
- Pembrolizumab
- Ipilimumab
- Pemetrexed
- Dabrafenib Mesylate
- Carboplatin
Breakdown of trials John C. McCann has run
Lung Cancer
Non-Small Cell Lung Cancer
Melanoma
Skin Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John C. McCann specialize in?
John C. McCann focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is John C. McCann currently recruiting for clinical trials?
Yes, John C. McCann is currently recruiting for 5 clinical trials in Springfield Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that John C. McCann has studied deeply?
Yes, John C. McCann has studied treatments such as Nivolumab, Pembrolizumab, Ipilimumab.
What is the best way to schedule an appointment with John C. McCann?
Apply for one of the trials that John C. McCann is conducting.
What is the office address of John C. McCann?
The office of John C. McCann is located at: Baystate Medical Center, Springfield, Massachusetts 01199 United States. This is the address for their practice at the Baystate Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.